These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 16140176)
1. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176 [TBL] [Abstract][Full Text] [Related]
2. Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats. Al Mutairy A; Al Kadasah S; Elfaki I; Arshaduddin M; Malik D; Al Moutaery K; Tariq M Neurotoxicol Teratol; 2010; 32(2):226-33. PubMed ID: 19755148 [TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats. Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype. Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998 [TBL] [Abstract][Full Text] [Related]
5. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats. Dhir A; Akula KK; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412 [TBL] [Abstract][Full Text] [Related]
6. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats. Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations. Kumar P; Kumar A Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Kumar P; Kumar A Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383 [TBL] [Abstract][Full Text] [Related]
9. Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid. Lagoa R; Lopez-Sanchez C; Samhan-Arias AK; Gañan CM; Garcia-Martinez V; Gutierrez-Merino C J Neurochem; 2009 Oct; 111(2):473-87. PubMed ID: 19682208 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889 [TBL] [Abstract][Full Text] [Related]
11. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443 [TBL] [Abstract][Full Text] [Related]
13. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988 [TBL] [Abstract][Full Text] [Related]
14. Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease. Park JE; Lee ST; Im WS; Chu K; Kim M Neurosci Lett; 2008 Dec; 448(1):143-7. PubMed ID: 18938211 [TBL] [Abstract][Full Text] [Related]
15. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro. Colle D; Hartwig JM; Soares FA; Farina M Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028 [TBL] [Abstract][Full Text] [Related]
16. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Diguet E; Fernagut PO; Wei X; Du Y; Rouland R; Gross C; Bezard E; Tison F Eur J Neurosci; 2004 Jun; 19(12):3266-76. PubMed ID: 15217383 [TBL] [Abstract][Full Text] [Related]
17. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease. Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076 [TBL] [Abstract][Full Text] [Related]
18. Involvement of mGlu5 receptor in 3-nitropropionic acid-induced oxidative stress in rat striatum. Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR Neurol Res; 2014 Sep; 36(9):833-40. PubMed ID: 24588139 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model. Yanagida T; Takeuchi H; Kitamura Y; Takata K; Minamino H; Shibaike T; Tsushima J; Kishimoto K; Yasui H; Taniguchi T; Shimohama S Neurosci Res; 2008 Dec; 62(4):254-61. PubMed ID: 18845194 [TBL] [Abstract][Full Text] [Related]
20. Nicotine induces tyrosine hydroxylase plasticity in the neurodegenerating striatum. Urbanavicius J; Ferreira M; Costa G; Abin-Carriquiry JA; Wonnacott S; Dajas F J Neurochem; 2007 Aug; 102(3):723-30. PubMed ID: 17437548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]